

Fundamental dimension Equity attribute | LMTLeader $605.48▲+2.64% Cap $139.7BP/E 21.4x QuantScore54/100 | BAPeer $188.44▲+0.47% Cap $148.9BP/E 70.6x QuantScore48/100 | BAESYPeer $103.33▼-0.81% Cap $75.58BP/E 27.6x QuantScore45/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
64/100 |
46/100 |
61/100 |
Valuation Multiples, PEG & DCF upside | 89/100 | 37/100 | 68/100 |
Health Piotroski, Altman Z, leverage & liquidity | 42/100 | 17/100 | 43/100 |
Growth Revenue / earnings growth & margins | 14/100 | 50/100 | 31/100 |
Sentiment Analyst ratings, targets & revisions | 59/100 | 88/100 | 19/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 21.4x | 70.6x | 27.6x |
Forward P/E (next FY) | 19.9x | -178.7x | 30.7x |
EV / EBITDA (TTM) | 14.7x | 24.9x | 16.0x |
Price / Sales | 1.8x | 1.6x | 1.9x |
Price / Free Cash Flow | 16.7x | -709.2x | 12.5x |
PEG ratio | 0.37 | 0.38 | 3.59 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 6 / 9 | 9 / 9 |
Altman Z-Score | 3.66 (Safe) | 1.48 (Distress) | 2.42 (Grey) |
Total debt / equity | 2.04 | 7.52 | 0.74 |
Quick ratio | 1.1x | 0.3x | 0.9x |
Interest coverage | 8.6x | -2.0x | 5.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +5.7% | +34.5% | +7.7% |
Net income growth YoY | -6.0% | +118.9% | +5.4% |
Gross margin (TTM) | 11.7% | 4.7% | 26.0% |
Operating margin (FY) | 10.3% | 4.8% | 9.2% |
FCF margin (FY) | 9.2% | -2.1% | 8.2% |
5. Trailing price performancePrice change over period |
1M return | +15.4% | -4.3% | -1.9% |
3M return | +3.7% | -10.1% | -1.6% |
6M return | +17.7% | -19.0% | -6.0% |
Year to date | +24.9% | -13.3% | +11.5% |
1Y return | +24.5% | -14.9% | +4.5% |
3Y return | +37.0% | +3.3% | +93.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $763.24 +26.1% upside | $-430.94 -328.7% premium | $134.84 +30.5% upside |
Wall Street consensus target | $627.82 +3.7% · range $560.00–$700.00 | $270.33 +43.5% · range $225.00–$305.00 | $113.00 +9.4% · range $113.00–$113.00 |
Consensus stance | 59% Buy38% Hold3% Sell | 69% Buy22% Hold9% Sell | 0% Buy67% Hold33% Sell |